In order to study the role of annexin Ⅱ, a recombinant expression vector, pZeoSV2(+)ANN Ⅱ, containing the annexin Ⅱ cDNA , was developed. The 1.1 kb length annexin Ⅱ cDNA was inserted into a express ion vector,...In order to study the role of annexin Ⅱ, a recombinant expression vector, pZeoSV2(+)ANN Ⅱ, containing the annexin Ⅱ cDNA , was developed. The 1.1 kb length annexin Ⅱ cDNA was inserted into a express ion vector, PZeoSV(+) and transfected into HL 60 cells which had low baseline e xpression of Ann Ⅱ. pZeoSV(+) ANNⅡ was analyzed by restriction mapping and th e Ann Ⅱ sequence identified. The ability of the transfected cells, non transf ected and mock transfected cells to stimulate t PA depend plasminogen activat ion was compared. The results showed that HL 60 with pZeoSV(+)ANNⅡ transfectio n could significantly increase the plasminogen activation (8.9±1.2 U) in vitr o with the difference being significant as compared with non transfected (1.5±0. 4 U) and mock transfected cells (4.2±0.9 U), respectively. AntiannexinⅡoligon ucleotides significantly inhibited the binding ability of t PA and plasminogen to annexinⅡ, and obviously reduced the plasminogen activation in vitro . The above findings showed human umbilical vein endothelial cells (HUVECs) treated w ith sense or missense oligonucleotides indicated no significant change in bindin g of t PA and PLG. Treatment of HUVECs with antiannexin Ⅱ oligonucleotides cou ld significantly reduce the plasminogen activation by 2.4±0.3 U as compared wit h sense oligonucleotide group in binding of t PA and PLG. These results, theref ore, suggest that Ann Ⅱ can bind plasminogen and participate in the stimulatio n of t PA dependent activation of plasminogen, and that interference with Ann Ⅱ mRNA by antisense oligonucleotide may be a new strategy for the therapy of bleeding in patients with hyperfibrinolysis.展开更多
An isoindolone derivative, Fungi fibrinolytic compound （R）-2,5-bis（（2R,3R）-2-（（E）-4,8-dimethylnona-3,7-dien- 1-y1）-3,5-dihydroxy-2-methy--7-oxo-3,4,7,9-tetrahydr pyrano[2,3-e]isoindol-8（2H）-yl）pentanoic ac...An isoindolone derivative, Fungi fibrinolytic compound （R）-2,5-bis（（2R,3R）-2-（（E）-4,8-dimethylnona-3,7-dien- 1-y1）-3,5-dihydroxy-2-methy--7-oxo-3,4,7,9-tetrahydr pyrano[2,3-e]isoindol-8（2H）-yl）pentanoic acid （FGFC1, Fungi fibrinolytic compound 1）, was isolated from a rare marine microorganism strain Stachybotrys longispora FG216. The structure of FGFC1 was elucidated by 1H NMR, 13C NMR, IR, and MS data; moreover, it was also evaluated for fibrinolytic activity in vitro and in vivo. The results showed that 0.1--0.4 mmol/L of FGFC1 could stimulate generation of plasmin activity （increased by 2.05--11.44 folds） by measuring Glu-plasminogen and Lys-plasminogen activation in vitro. The experiment of fluorescein isothiocyanate （FITC）-fibrinogen degradation indicated that the effect of FGFCI on fibrinolytic activity was mediated by plasminogen and scuPA. In addition, FGFC 1 （10 mg/kg） could dissolve most of pulmonary thrombus of Wistar rat in vivo. It is possible that FGFC 1 is a potential thrombolytic agent in the future.展开更多
文摘In order to study the role of annexin Ⅱ, a recombinant expression vector, pZeoSV2(+)ANN Ⅱ, containing the annexin Ⅱ cDNA , was developed. The 1.1 kb length annexin Ⅱ cDNA was inserted into a express ion vector, PZeoSV(+) and transfected into HL 60 cells which had low baseline e xpression of Ann Ⅱ. pZeoSV(+) ANNⅡ was analyzed by restriction mapping and th e Ann Ⅱ sequence identified. The ability of the transfected cells, non transf ected and mock transfected cells to stimulate t PA depend plasminogen activat ion was compared. The results showed that HL 60 with pZeoSV(+)ANNⅡ transfectio n could significantly increase the plasminogen activation (8.9±1.2 U) in vitr o with the difference being significant as compared with non transfected (1.5±0. 4 U) and mock transfected cells (4.2±0.9 U), respectively. AntiannexinⅡoligon ucleotides significantly inhibited the binding ability of t PA and plasminogen to annexinⅡ, and obviously reduced the plasminogen activation in vitro . The above findings showed human umbilical vein endothelial cells (HUVECs) treated w ith sense or missense oligonucleotides indicated no significant change in bindin g of t PA and PLG. Treatment of HUVECs with antiannexin Ⅱ oligonucleotides cou ld significantly reduce the plasminogen activation by 2.4±0.3 U as compared wit h sense oligonucleotide group in binding of t PA and PLG. These results, theref ore, suggest that Ann Ⅱ can bind plasminogen and participate in the stimulatio n of t PA dependent activation of plasminogen, and that interference with Ann Ⅱ mRNA by antisense oligonucleotide may be a new strategy for the therapy of bleeding in patients with hyperfibrinolysis.
文摘An isoindolone derivative, Fungi fibrinolytic compound （R）-2,5-bis（（2R,3R）-2-（（E）-4,8-dimethylnona-3,7-dien- 1-y1）-3,5-dihydroxy-2-methy--7-oxo-3,4,7,9-tetrahydr pyrano[2,3-e]isoindol-8（2H）-yl）pentanoic acid （FGFC1, Fungi fibrinolytic compound 1）, was isolated from a rare marine microorganism strain Stachybotrys longispora FG216. The structure of FGFC1 was elucidated by 1H NMR, 13C NMR, IR, and MS data; moreover, it was also evaluated for fibrinolytic activity in vitro and in vivo. The results showed that 0.1--0.4 mmol/L of FGFC1 could stimulate generation of plasmin activity （increased by 2.05--11.44 folds） by measuring Glu-plasminogen and Lys-plasminogen activation in vitro. The experiment of fluorescein isothiocyanate （FITC）-fibrinogen degradation indicated that the effect of FGFCI on fibrinolytic activity was mediated by plasminogen and scuPA. In addition, FGFC 1 （10 mg/kg） could dissolve most of pulmonary thrombus of Wistar rat in vivo. It is possible that FGFC 1 is a potential thrombolytic agent in the future.
